Please login to the form below
Shingrix
This page shows the latest Shingrix news and features for those working in and with pharma, biotech and healthcare.
GSK’s shingles vaccine demonstrates at least ten-year efficacy in long-term study
GSK’s Shingrix (zoster vaccine recombinant, adjuvanted) can provide at least a decade of protection against shingles (herpes zoster) after initial vaccination, according to interim results from the company’s
Latest news
-
GSK beats expectations thanks to strong vaccine sales in Q2
However, sales of its shingles jab Shingrix increased by only 1% on a constant currency basis, although the drugmaker is expecting strong growth from the vaccine in the second half of
-
GSK’s revenue drops by 18% in Q1 as performance pressures mount
Shingrix. Walmsley pinned GSK’s growth prospects on the launch of its HIV pill Cabenuva, as well as a potential RSV vaccine, currently in phase 3 trials, and a new ... GSK is confident that sales of Shingrix will increase in the second half of the year,
-
Pfizer, Sanofi and others set to increase US drug prices in 2021
Pfizer and Sanofi are planning to keep almost all of their increase at 5% or lower, 3 Axis added, with GSK also increasing their prices of two vaccines, Shingrix and Pediarix,
-
GSK considers more divestments to help R&D push
Looking at the fourth quarter numbers, pharma sales slumped 5% to £4.6bn, but there was an encouraging 18% gain for vaccines to £1.74bn thanks to strong growth for Shingrix,
-
GSK boosts outlook thanks to strong respiratory and vaccine sales
Key Q3 drivers include Shingrix vaccine and asthma drug Nucala. GlaxoSmithKline has raised its profit forecast for the second consecutive quarter thanks to the strong sales of its shingles vaccine Shingrix ... Also bringing the forecast up is GSK’s
More from news
Approximately 9 fully matching, plus 23 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2018
In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- Eli Lilly announces $450m investment in US manufacturing site
- Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- Tidepool’s automated insulin dosing app for type 1 diabetes gets FDA approval
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Alzheimer’s Society urges UK government to deliver on dementia plan
- GSK fires senior Chinese scientist over data fabrication
- NICE set to recommend seven biologics for severe rheumatoid arthritis
- World Cancer Day: encouraging men to put their health first
PMHub
Medscape Medical Affairs
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
